Clinical trial · Observational
A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Early-stage non small cell lung cancer represents 20-30% of all non small cell lung cancer and is characterized by a high survival probability after surgical resection. However, considering stage IA-IIIA non small cell lung cancer, a relapse rate of about 50% is observed, with a different survival probability on the basis of tumor node metastasis status, although patients within the same tumor node metastasis stage exhibit wide variations in recurrence rate. There are currently no validated prognostic biomarkers able to identify patients with a high risk of relapse.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-small Cell Lung Cancer Stage IIIA | Lung Non-Small Cell Carcinoma | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Resected non small cell lung cancer | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Resected early stage non small cell lung cancer
- description
- Early stage (IA-IIIA) resectable non small cell lung cancer patients receiving surgery
- interventionNames
- Other: Resected non small cell lung cancer
Primary outcomes (1)
- measure
- Algorithm for disease free survival
- timeFrame
- 18 months
- description
- Analysis on a training cohort of resected early-stage non small cell lung cancer
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient with an early stage of non small cell lung cancer * Indication of surgical resection * Patient able to understand and give his consent * Patient affiliated to the health insurance Exclusion Criteria: * Patient with another cancer in the last 5 years * Patient with an allergy to the contrast medium * Patient under legal protection
References
Publications (0)
Data not yet available